FOSUN PHARMA
Live / Registered — Registered (as of 07 Oct 2025)
What this means for you
Registered since 07 Oct 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Oct 2031: the §71 affidavit of use).
Record
- Serial number
- 79407348
- Registration number
- 7971544
- Mark type
- Stylized text
- Filed
- 05 Jul 2024
- Published for opposition
- 19 Aug 2025
- Registered
- 07 Oct 2025
- Next maintenance filing
- §71 affidavit of use, due by 07 Oct 2031 (grace period to 07 Apr 2032)
- Attorney of record
- John Alumit
Goods and services
- Class 005 — Pharmaceuticals: Antiseptics; chemico-pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; anaesthetics; pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; vaccines; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; pharmaceuticals for the treatment of cancer; balsamic preparations for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; biological preparations for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; medicines for human purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; diagnostic preparations for medical purposes
- Class 010 — Medical apparatus: Medical apparatus and instruments for use in treating all treatable diseases, illnesses, and medical conditions for humans
- Class 035 — Advertising and business services: Retail store or wholesale store services for medical supplies; retail store or wholesale store services for medicines; retail store or wholesale store services for pharmaceutical preparations; marketing services; sales promotion for others
- Class 042 — Scientific and technological services: Pharmaceutical drug development; pharmaceutical research; conducting clinical trials for others
Owner
Prosecution history
- 30 Apr 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Apr 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Apr 2026 — FINAL DISPOSITION PROCESSED
- 09 Apr 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 07 Jan 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jul 2025 — EXAMINER'S AMENDMENT ENTERED